ESC Premium Access

A systematic review and meta-analysis of health-related quality of life (HRQoL) outcomes in randomised controlled trials for pulmonary arterial hypertension (PAH)

Congress Presentation

About the speaker

Doctor Frances Varian

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

7 more presentations in this session

Improving morbidity and mortality in patients with pulmonary hypertension: insights from a nation-wide registry

Speaker: Professor C. Kaymaz (Istanbul, TR)

Thumbnail

Real-world evidence on pulmonary arterial hypertension: interim analysis from the Italian observational study INSPECTIO

Speaker: Associate Professor M. D'Alto (Naples, IT)

Thumbnail

Idiopathic pulmonary arterial hypertension, associated with connective tissue disease and comorbidities: prognostic differences? Results the Spanish Registry of pulmonary hypertension (REHAP Registry)

Speaker: Doctor R. Bravo-Marques (Marbella, ES)

Thumbnail

Clinical, echocardiographic and haemodynamic predictors of morbidity and mortality in pulmonary hypertension: a nation-wide registry

Speaker: Professor C. Kaymaz (Istanbul, TR)

Thumbnail

The importance of comorbidities in idiopathic and associated with connective tissue disease pulmonary arterial hypertension: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)

Speaker: Doctor R. Bravo-Marques (Marbella, ES)

Thumbnail

Access the full session

Pulmonary hypertension: insights from registries, retrospective data sets, and meta-analyses

Speakers: Doctor F. Varian, Professor C. Kaymaz, Associate Professor M. D'Alto, Doctor R. Bravo-Marques, Professor C. Kaymaz...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations